EUFOREA treatment algorithm for allergic rhinitis

Autor: Hellings, P. W., Scadding, G., Bachert, C., Bjermer, L., Canonica, G. W., Cardell, L. O., Carney, A. S., Constantinidis, J., Deneyer, L., Diamant, Z., Durham, S., Gevaert, P., Harvey, R., Hopkins, C., Kjeldsen, A., Klimek, L., Lund, V. J., Price, D., Rimmer, J., Ryan, D., Roberts, G., Sahlstrand-Johnson, P., Salmi, S., Samji, M., Scadding, Guy, Smith, P., Steinsvik, A., Wagenmann, M., Seys, S., Wahn, U., Fokkens, W. J.
Přispěvatelé: Ear, Nose and Throat, AII - Inflammatory diseases
Rok vydání: 2020
Předmět:
Zdroj: Rhinology, 58(6), 1-5. University Hospital Utrecht
Hellings, P W, Scadding, G, Bachert, C, Bjermer, L, Canonica, G W, Cardell, L O, Carney, A S, Constantinidis, J, Deneyer, L, Diamant, Z, Durham, S, Gevaert, P, Harvey, R, Hopkins, C, Kjeldsen, A, Klimek, L, Lund, V J, Price, D, Rimmer, J, Ryan, D, Roberts, G, Sahlstrand-Johnson, P, Salmi, S, Samji, M, Scadding, G, Smith, P, Steinsvik, A, Wagenmann, M, Seys, S, Wahn, U & Fokkens, W J 2020, ' EUFOREA treatment algorithm for allergic rhinitis ', Rhinology, vol. 58, no. 6, pp. 618-622 . https://doi.org/10.4193/Rhin20.246
Rhinology, 58(6), 618-622. INT RHINOLOGIC SOC
ISSN: 0300-0729
Popis: Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1). Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), and under-treated (3). Although effective and safe treatments exist, patients wait too long to seek medical advice, often preferring to self-manage at drug stores and at the pharmacy (4).
Databáze: OpenAIRE